Azelaic Acid Technical Guide: Concentration Limits, Solubility & Grade Selection | Onerchem
Azelaic Acid Technical Guide: Concentration Limits, Solubility Problem & Grade Selection for B2B Buyers
Most azelaic acid content focuses on concentration — 10%, 15%, 20%. The more important question for formulators and OEM buyers is rarely asked: how are you suspending it? Azelaic acid dissolves in water at only 0.24%. Every product above 1% is a suspension system. Particle size, milling grade, and suspension stability determine product performance more than concentration alone.
What Azelaic Acid Is
Azelaic acid (nonanedioic acid, CAS 123-99-9) is a saturated, nine-carbon dicarboxylic acid. It occurs naturally in grains — wheat, rye, barley — and is also produced endogenously on human skin by Malassezia furfur, a yeast species that is part of the normal skin microbiome. ✅ Verified — CosmeticsScience.net; PubMed review
For commercial cosmetic and pharmaceutical use, azelaic acid is produced synthetically by ozonolysis of oleic acid (from sunflower or other vegetable oils), followed by purification and micronisation. The synthesis route makes it fully vegetarian and free of animal-derived materials.
Azelaic acid is a white, crystalline powder with the following physical properties relevant to formulation:
- Molecular weight: 188.22 g/mol
- Melting point: 106–111°C
- Water solubility: ~0.24% w/w at 20°C — practically insoluble at room temperature ✅ Verified — US Patent 5925679; Azeco technical data
- Solubility in oils: Little to none — does not dissolve in typical cosmetic lipid phases
- pKa: 4.55 (pKa1) — behaves as a weak acid in formulation systems
These physical properties make azelaic acid genuinely challenging to formulate at effective concentrations — a fact that is underappreciated in most supplier documentation and product briefs.
Four Mechanisms of Action
Azelaic acid is multi-functional. Its clinical applications span acne, rosacea, hyperpigmentation, and post-inflammatory hyperpigmentation (PIH), because it operates through four distinct but complementary mechanisms simultaneously.
| Mechanism | Target | Clinical Application | Evidence Level |
|---|---|---|---|
| Tyrosinase inhibition | Melanin synthesis pathway — blocks conversion of tyrosine to DOPA | Hyperpigmentation, melasma, PIH, brightening | ✅ Multiple RCTs; comparable to 4% hydroquinone at 20% concentration |
| Antimicrobial | Cutibacterium acnes (formerly P. acnes) and Staphylococcus epidermidis — disrupts bacterial protein synthesis | Acne vulgaris, comedolytic | ✅ FDA-approved at 20% for acne |
| Anti-inflammatory | Reactive oxygen species (ROS) scavenging; inhibits neutrophil superoxide generation | Rosacea, inflammatory acne, reactive skin | ✅ FDA-approved at 15% for rosacea |
| Keratolytic | Normalises keratinisation — reduces follicular hyperkeratosis | Acne, skin texture improvement, pore appearance | ⚠ Mechanism established; clinical evidence primarily at ≥10% |
Azelaic acid's multi-mechanism profile means it can be positioned in brightening, acne, rosacea, and sensitive skin product lines without reformulation. The same raw material at the same concentration serves different marketing angles depending on the target consumer and claims framework. This versatility makes it unusually efficient as a core active for OEM product development.
Concentration, Regulation & the Cosmetic/Pharmaceutical Boundary
Azelaic acid's regulatory status is concentration-dependent, and the boundary between cosmetic and pharmaceutical classification varies by market. This is the first decision a B2B buyer or product developer must make — it determines not just the formulation target but the entire regulatory pathway.
| Market | Cosmetic (no prescription) | OTC / Quasi-drug | Prescription required |
|---|---|---|---|
| EU | ≤10% — freely permitted as cosmetic | 10–15% — grey zone, dermo-cosmetic claims | ≥15% — medicinal product, requires authorisation |
| USA (FDA) | <15% — cosmetic use, no prescription | No distinct OTC category for azelaic acid | 15% gel (rosacea) and 20% cream (acne) — FDA-approved drugs, prescription only |
| UK | ≤10% — cosmetic | 10–14% — dermo-cosmetic boundary | ≥15% — prescription medicine (Finacea®, Skinoren®) |
| China (NMPA) | Listed as permitted cosmetic ingredient; concentration guidance follows EU broadly | Whitening claims require special cosmetic registration | Pharmaceutical applications require drug registration |
| South Korea (MFDS) | Permitted in cosmetics | Functional cosmetic registration for whitening or acne claims at higher concentrations | Pharmaceutical at therapeutic concentrations |
If your customers sell into the EU or UK, formulate to ≤10% azelaic acid for cosmetic status without complexity. Products at 10–14% occupy a regulatory grey zone that requires careful claims management. Any product at ≥15% is a pharmaceutical in EU/UK and requires medicinal product authorisation — this is not a cosmetic ingredient procurement question at that point, it is a pharmaceutical development question. The raw material is the same; the regulatory pathway is entirely different.
For most cosmetic OEM applications, the practical working range is 5–10%, which delivers meaningful brightening and skin texture improvement while maintaining cosmetic regulatory status in all major markets. Studies confirm that 10% azelaic acid achieves noticeable tone improvement within 8–12 weeks of daily use. ✅ Verified — CosmeticsScience.net review of clinical data
The Solubility Problem: Why Every Azelaic Acid Product Above 1% Is a Suspension
This is the most important technical fact about azelaic acid formulation, and it is the one most consistently absent from supplier product pages and generic technical guides.
Azelaic acid dissolves in water at approximately 0.24% w/w at room temperature. ✅ Verified — US Patent 5925679; Azeco technical documentation It has negligible solubility in cosmetic oils. It is sparingly soluble in alcohols, but the concentrations of alcohol required to dissolve cosmetically relevant quantities of azelaic acid are too high for leave-on skincare formulations.
A 10% azelaic acid product contains approximately 42 times more azelaic acid than water can dissolve at room temperature. The ingredient is not in solution — it is suspended as solid particles throughout the formulation.
— The fundamental formulation reality of every azelaic acid product at cosmetic use concentrationsThis has direct implications for product performance, stability, and sensory experience:
- Skin penetration is surface-area dependent: Azelaic acid must dissolve from the particle surface into the skin before it can be absorbed. Smaller particles = more surface area = faster dissolution rate = better skin penetration at equal weight concentration
- Gritty texture: Larger particles produce a sandy or gritty feel in formulations. This is the most common consumer complaint about azelaic acid products and is a direct consequence of insufficient milling
- Sedimentation: In suspension systems, particles settle over time unless stabilised by rheology modifiers. Poor suspension stability creates product separation and inconsistent dosing
- Appearance: Well-milled azelaic acid creates smooth, opaque white formulations. Poorly milled material creates visible white streaks or grainy texture even in cream bases
How Solubility Can Be Enhanced
Several approaches are used commercially to increase effective azelaic acid incorporation:
- Alkaline neutralisation to azelate salt: At pH >5.5, azelaic acid partially ionises to its azelate anion, which is more water-soluble than the free acid. Partial neutralisation with potassium hydroxide or triethanolamine improves solubility while maintaining efficacy. Used in gel formulations. ✅ Verified — GrandIngredients formulation guide; Azeco data
- Polar solvent addition: Propylene glycol, ethoxydiglycol, ethoxytriglycol, and pentylene glycol all improve azelaic acid solubility significantly. These are the standard approach for suspension-type serums and creams
- Microemulsion systems: PubMed research shows microemulsion carriers with droplet sizes of 5–150 nm significantly increase follicular delivery compared to standard suspensions ✅ Verified — PMC7191225
- Nanosuspension: Commercial-scale nanosuspensions (particle size 326–541 nm) have been demonstrated to achieve 20% drug loading with good stability ✅ Verified — PMC12030390 (Pharmaceutics, 2025)
For standard OEM cosmetic applications, the practical approach is: micronised azelaic acid (D90 ≤10μm) + polar solvent addition (propylene glycol or ethoxydiglycol at 5–10%) + rheology modifier for suspension stability.
Particle Size: The Specification Most COAs Don't Include But Should
Particle size is the single most important quality parameter for azelaic acid beyond purity — yet the majority of supplier COAs do not include it. This is a critical gap for OEM buyers.
The commercially recognised benchmark for cosmetic-grade azelaic acid is a D90 particle size of ≤10 μm — meaning 90% of particles are below 10 micrometres. This is the specification used by pharmaceutical-grade suppliers for cosmetic applications. ✅ Verified — BASF Dermaz99® product specification (D90 ≤10μm); PMC12030390
| Particle Size (D90) | Skin Feel | Penetration Efficiency | Suspension Stability | Application |
|---|---|---|---|---|
| <5 μm | Smooth, silky | High | Good | Premium serums, high-performance formulas |
| 5–10 μm | Smooth | Good | Good | Standard cosmetic grade — industry benchmark |
| 10–30 μm | Slightly rough | Moderate | Requires stabiliser | Acceptable for cream formats with high emollient content |
| >30 μm | Gritty / sandy | Low | Poor without heavy thickener | Not suitable for cosmetic skin contact applications |
Accepting an azelaic acid COA that shows "≥99% purity" without particle size data, then experiencing gritty texture or poor performance in the finished product. The purity was correct — the problem was particle size. A ≥99% purity figure tells you the compound is present and pure; it tells you nothing about the physical form that determines formulation behaviour. Always request D90 particle size data alongside purity.
For OEM buyers, the practical procurement requirement is: cosmetic-grade azelaic acid with ≥99% purity by HPLC and D90 particle size ≤10μm, with particle size data declared on the batch COA.
Formulation Parameters
pH Range
Azelaic acid performs best in mildly acidic systems at pH 4.5–5.5. This range preserves antimicrobial efficacy and skin compatibility. ✅ Verified — GrandIngredients formulation guide Below pH 4.0, increased free acid concentration can cause irritation. Above pH 6.0, solubility improves due to ionisation but antimicrobial and keratolytic properties decrease as the free acid converts to azelate salt. For brightening-focused formulations where antimicrobial activity is secondary, slightly higher pH (5.5–6.5) can improve skin compatibility.
If combining azelaic acid with niacinamide in the same formulation, target pH ≥5.5. At lower pH with heat, niacinamide can partially convert to nicotinic acid (niacin), which causes skin flushing. Azelaic acid and niacinamide are mechanistically complementary for brightening — both are tyrosinase inhibitors — and the combination is clinically well-supported, but pH management is essential. See the Niacinamide Supplier Guide for detailed niacinamide formulation parameters.
Addition Protocol
Azelaic acid should be added to the water phase post-emulsification, during cool-down at approximately 40°C or below. Adding to the hot phase causes unnecessary thermal exposure and does not improve dispersion because it remains as a suspension regardless of temperature in standard cosmetic systems. Pre-wet the powder with a small amount of glycol solvent before adding to the bulk to improve dispersion and minimise agglomeration.
Suspension Stabilisation
For formulations above 3% azelaic acid, a suspension stabiliser is required to prevent particle sedimentation during shelf life. Effective options include:
- Carbomer or carbopol (0.2–0.5%) — forms a polymer network that suspends particles through yield stress
- Xanthan gum (0.2–0.4%) — biopolymer suspending agent, compatible across a wide pH range
- HPMC (0.5–1.0%) — useful in gel formulations; also stabilises nanosuspensions ✅ Verified — PMC12030390
- Acrylate polymers — provide both thickening and suspension stability in water-based serums
Packaging Considerations
Azelaic acid suspensions require packaging that minimises particle settling and maintains consistent dosing per application:
- Pump dispensers: Preferred — maintains suspension homogeneity through the pump mechanism
- Airless bottles: Best option for high-concentration formulations — prevents oxidation and maintains dosing consistency
- Open-mouth jars: Not recommended for suspension formulations — particle settling creates inconsistent application and potential hygiene issues
Compatibility
Azelaic acid is broadly compatible with most cosmetic actives at typical use concentrations. Well-documented synergistic combinations include:
- Niacinamide — complementary tyrosinase inhibition + melanin transfer inhibition; manage pH as noted above
- Alpha-arbutin — additive brightening from different pathway points
- Tranexamic acid — upstream MITF suppression complements azelaic acid's tyrosinase inhibition for PIH
- Panthenol — barrier support reduces the mild transient irritation some users experience at higher azelaic acid concentrations
Avoid combining with high concentrations of strong anionic polymers without compatibility testing, and avoid using in anhydrous/oil-only systems where azelaic acid cannot disperse.
COA Verification Checklist
Onerchem's Azelaic Acid
Onerchem supplies cosmetic-grade azelaic acid for bulk OEM manufacturing. Available in standard cosmetic grade (≥99% HPLC, D90 ≤10μm) suitable for brightening serums, acne treatment products, rosacea-targeted formulations, and multi-functional skin tone correction products.
Batch-specific COA: HPLC assay ≥99%, particle size D90 ≤10μm, melting point, heavy metals by ICP, loss on drying, dibasic acid impurity profile · MSDS · MOQ 50kg · In-stock orders dispatch 3–7 days · Sample available before bulk order commitment
For formulations combining azelaic acid with complementary brightening actives, Onerchem also supplies niacinamide, alpha-arbutin, and tranexamic acid for multi-active brightening system development.
Request Azelaic Acid Samples or Bulk Pricing
≥99% HPLC, D90 ≤10μm. Particle size data on batch COA. MOQ 50kg.
Frequently Asked Questions
Yang Ruosong oversees ingredient sourcing and technical documentation at Onerchem. Onerchem supplies bulk cosmetic ingredients to OEM manufacturers and cosmetic brands globally. MOQ 50kg. See the Knowledge Hub or request bulk pricing.